Morgan Stanley raises target for Amplifon stock to EUR 14.96

Published on 10/14/2026 at 12:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgan Stanley kept Overweight on October 9. Amplifon stock stands at EUR 12.69, 0.71 percent above the Xetra close of October 13, 2026.

Earnings and valuation milestones

Morgan Stanley lifted its Amplifon target to EUR 14.96 from EUR 14.90 on October 9, 2026.
First-half 2026 revenue reached EUR 1,185.7 million, with organic growth of 3.50 percent.
Amplifon stock trades at EUR 12.69 at 12:43 p.m. CEST on October 14, 2026, 0.71 percent above the Xetra close of October 13, 2026.

Bauhaus-Poster mit geometrischen Formen und dem Wort HEALTH in Blockschrift — Bauhaus-Poster mit geometrischen Formen und Sektor-Text repräsentiert Amplifon S.p.A., ISIN IT0004056880, im Bereich Medizintechnik, Illustration mit AI erstellt.

Amplifon (ISIN IT0004056880) was trading at EUR 12.69 at Lang & Schwarz on October 14, 2026, at 12:43 p.m. CEST, 0.71 percent above the Xetra close of October 13, 2026 at EUR 12.60. On October 9, 2026, Teleborsa reported that Morgan Stanley kept its Overweight recommendation and raised its target for Amplifon from EUR 14.90 to EUR 14.96.

Three milestones shape the valuation

On March 16, 2026, Amplifon announced the EUR 2.30 billion agreement to acquire GN Hearing from GN Store Nord, according to Capital.com. The transaction remains the central strategic variable because integration, financing and potential synergies can alter the earnings profile.

On July 30, 2026, Amplifon reported first-half revenue of EUR 1,185.7 million, up 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent, Capital.com said. Adjusted EBITDA rose 3.60 percent to EUR 298.0 million, and the adjusted EBITDA margin reached 25.10 percent.

On October 9, 2026, Morgan Stanley's target increase added a quantified valuation reference. The EUR 14.96 target lies 17.89 percent above the EUR 12.69 Lang & Schwarz price, using both values in euros.

What comes next for Amplifon

Amplifon's next scheduled release is the third-quarter and nine-month report on October 29, 2026, according to Capital.com. The company has also called a shareholder meeting for October 29, 2026, according to its official notice.

The operating numbers give the target increase a concrete test: revenue growth was positive in the first half, while margin expansion and the GN Hearing transaction remain the main execution measures for the next report.

Price and upcoming dates

Amplifon was trading at EUR 12.69 at Lang & Schwarz on October 14, 2026, at 12:43 p.m. CEST, 0.71 percent above the Xetra close of October 13, 2026 at EUR 12.60. The market capitalization was EUR 2.8 billion, and the 52-week range was EUR 7.84 to EUR 15.84 as of October 14, 2026. The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.